|
PDCL3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.663500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.380200E-02 |
| Normal-vs-Stage2 |
5.224200E-01 |
| Normal-vs-Stage3 |
7.692300E-02 |
| Normal-vs-Stage4 |
2.345600E-01 |
| Stage1-vs-Stage2 |
6.056800E-01 |
| Stage1-vs-Stage3 |
8.236800E-01 |
| Stage1-vs-Stage4 |
8.956000E-01 |
| Stage2-vs-Stage3 |
5.313600E-01 |
| Stage2-vs-Stage4 |
7.437200E-01 |
| Stage3-vs-Stage4 |
7.748200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.847500E-02 |
| Normal-vs-AfricanAmerican |
2.026200E-01 |
| Normal-vs-Asian |
2.209000E-01 |
| Caucasian-vs-AfricanAmerican |
9.937000E-01 |
| Caucasian-vs-Asian |
8.066400E-01 |
| AfricanAmerican-vs-Asian |
8.738200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.451370E-01 |
| Normal-vs-Female |
3.951700E-02 |
| Male-vs-Female |
8.504600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.151600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.894600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.661160E-01 |
| Normal-vs-Age(81-100Yrs) |
5.132400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.569970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.293400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.226800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.522200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.657200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.368800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.957400E-01 |
| Classical-VS-Follicular |
9.518700E-03 |
| Classical-VS-Other |
4.071200E-01 |
| Classical-VS-Normal |
6.356200E-03 |
| Tall-VS-Follicular |
2.525800E-02 |
| Tall-VS-Other |
2.879800E-01 |
| Tall-VS-Normal |
4.453500E-02 |
| Follicular-VS-Other |
8.751200E-01 |
| Follicular-VS-Normal |
5.466400E-01 |
| Other-VS-Normal |
9.503200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.929400E-01 |
| Normal-vs-N1 |
2.887000E-01 |
| N0-vs-N1 |
3.811600E-01 |
|
|
